1. The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen 
Alvaro Urbano-Ispizua, Steven Z. Pavletic, Mary E. Flowers, John P. Klein, Mei-Jie Zhang, Jeanette Carreras, Silvia Montoto, Miguel- Angel Perales, Mahmoud D. Aljurf, Görgün Akpek, Christopher N. Bredeson, Luciano J. Costa, Christopher Dandoy, César O. Freytes, Henry C. Fung, Robert Peter Gale, John Gibson, Mehdi Hamadani, Robert J. Hayashi, Yoshihiro Inamoto, David J. Inwards, Hillard M. Lazarus, David G. Maloney, Rodrigo Martino, Reinhold Munker, Taiga Nishihori, Richard F. Olsson, David A. Rizzieri, Ran Reshef, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sonali M. Smith, Gérard Socié, Baldeep Wirk, Lolie C. Yu, Wael Saber 
Biology of Blood and Marrow Transplantation 
Volume 21, Issue 10, Pages (October 2015)
DOI: /j.bbmt
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Overall survival of the different lymphoma subtypes, in the overall group.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Progression-free survival of the different lymphoma subtypes, in the overall group.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Cumulative incidence of relapse per lymphoma subtype in the overall group (A), in myeloablative conditioning (B), and in reduced-intensity conditioning (C).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
Landmark analysis at 180 days after RIC allo-HCT showing the cumulative incidence of relapse in patients who had: (1) no acute GVHD, no chronic GVHD (AG-N/CG-N); (2) acute GVHD, no chronic GVHD (AG-Y/CG-N); (3) no acute GVHD, chronic GVHD (AG-N/CG-Y); and (4) both acute GVHD and chronic GVHD (AG-Y/CG-Y) in (left) mantle cell lymphoma and in (right) follicular lymphoma.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions